SCHEMBL9549934

SCHEMBL9549934

COc1ccc2c(c1)C1CCN(CC=C(C)C)C(C1)N2C

nearest known ligand 0.42

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.42
GAA P10253 1/20 0.35
ACHE P22303 1/20 0.34
GBA1 P04062 1/20 0.34
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9550040 0.82 OPRK1 (0.38)
SCHEMBL9549926 0.79 SIGMAR1 (0.47) BCHEACHE
SCHEMBL9550005 0.79 FDFT1 (0.37)
SCHEMBL9550050 0.78 HTR1A (0.44) GAAALDH1A1
SCHEMBL9764582 0.70 OPRM1 (0.38)
SCHEMBL9549940 0.69 ACHE (0.42) BCHEACHEALDH1A1CYP1A2CYP2D6
Fumaric Acid SCHEMBL9549925 0.68 MEN1 (0.41) ALDH1A1
SCHEMBL9549928 0.68 CYP2D6 (0.37) CYP2D6
SCHEMBL9540887 0.67 ACHE (0.58) BCHEACHEALDH1A1CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL9537459 0.67 ACHE (0.57) BCHEACHECYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5264575-A Reacting 1,3-benzodiazocine-8-ol derivative with lutidine/2,6-/, triisoproylsilyltrifluoro methane, formed intermediate reacted with lithium chloride, tetrabutylammonium fluoride and isocyanate HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-11-23 US disclosed
US-5097033-A Aminoethyl quinoline 2-ones, intermediates for analgesic, and cholinergic agents for memory disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-03-17 US disclosed
US-5010083-A Cognition activator; Alzheimer*s disease HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1991-04-23 US disclosed
EP-0335292-A2 2,6-Methano-1,3-benzodiazocines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-10-04 EP disclosed